Please assess the completion status of the following clinical trial:

Trial Title: Effect of Desmopressin on the Nocturnal Micturition Frequency in Patients With Parkinson Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male patients with idiopathic Parkinson Syndrome~* 18 to 85 years~* Nocturnal Pollakisuria \> 2 mictions /night (documented in Screening phase )~* Na+ i.S \> 135 mmol/l~* Patient is able to understand all aspects and individual consequences of the clinical trial~* An informed consent signed and dated by the patient is available prior to any study specific treatment~* The study is consistent with the patients´ request for an appropriate treatment~Exclusion Criteria:~* Intake of the following concomitant medication: Carbamazepin, Oxcarbazepine, diuretics (Furosemide, Torasemide), non steroidal antiphlogistics, Loperamide, antidiuretic hormone analoga (besides study medication), drugs for treatment of bladder disfunction, in particular anticholinergics~* Central Diabetes insipidus~* Known heart insufficiency (NYHA Stad. III und IV)~* clinical relevant kidney insufficiency~* Habitual and psychogenic Polydipsia~* Hypersensitivity or allergy against the trial medication or any other ingredient of the trial medication~* Participation in another clinical trial during or within 6 months prior to this clinical trial~* Medical or psychological condition, which might endanger the proper conduction of the clinical trial~* Known drug or alcohol abuse

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Desmopressin (Type: EXPERIMENTAL): Desmopressin 0,2 mg once daily and Desmopressin 0,2 mg bid for one week each.

Based on this trial design, predict the completion outcome and termination type (if applicable).